C12N 2795/10351
Methods of production or purification of viral material
C12N2795/10351 (Methods of production or purification of viral material) appears on 23 US grants and 36 published applications in this corpus.
Search patents in C12N- Granted patents
- 23
- Published applications
- 36
- Assignees
- 16
- Inventors
- 65
- Latest grant
- 4 Nov 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1992 | 1 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 1 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 1 |
| 2014 | 1 | 2 |
| 2015 | 0 | 1 |
| 2016 | 1 | 3 |
| 2017 | 2 | 2 |
| 2018 | 1 | 1 |
| 2019 | 2 | 1 |
| 2020 | 0 | 2 |
| 2021 | 1 | 0 |
| 2022 | 1 | 6 |
| 2023 | 6 | 3 |
| 2024 | 4 | 9 |
| 2025 | 2 | 1 |
| 2026 | 0 | 4 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Phage-derived particles for in situ delivery of DNA payload into C. acnes population4 Nov 2025US 12,460,216 B2Eligo Bioscience
- Cutibacterium acnes recombinant phages encoding a human protein28 Oct 2025US 12,454,696 B2Eligo Bioscience
- Method for purification of bacteriophage particles11 Jun 2024US 12,006,517 B2Adaptive Phage Therapeutics, Inc.
- Phage-derived particles for in situ delivery of DNA payload into C. acnes population30 Apr 2024US 11,970,701 B2Eligo Bioscience
- Production of lytic phages9 Apr 2024US 11,952,595 B2Eligo Bioscience
- Cutibacterium acnes recombinant phages, method of production and uses thereof6 Aug 2026US 2026/0226484 A1Eligo Bioscience
- Phage-derived particles for in situ delivery of dna payload into c. acnes population23 Apr 2026US 2026/0109991 A1Eligo Bioscience
- Atomic layer deposition (ald) processes applied to phage and phage-like particle platform yield thermostable therapeutic agents15 Jan 2026US 2026/0014093 A1The Regents of the University of Colorado, a body corporate
- Compositions and methods of use for stabilizing and delivery of atomic layer deposition coating of agent-containing lipid-emulsion formulations1 Jan 2026US 2026/0000621 A1The Regents of the University of Colorado, a body corporate
- Bacteriophage lambda-vaccine system13 Mar 2025US 2025/0082745 A1The U.S.A., as represented by the Secretary, Department of Health and Human Services
Most cited
By later US patents
- Preservation of viruses124US 5,149,653 AQuadrant Bioresources Limited · 1992
- Non-replicative transduction particles and transduction particle-based reporter systems11US 9,388,453 B2GeneWeave Biosciences, Inc. · 2016
- Method for isolating mutant cells4US 5,646,030 APresident and Fellows of Harvard College · 1997
- Non-replicative transduction particles and transduction particle-based reporter systems4US 9,771,622 B2GeneWeave Biosciences, Inc. · 2017
- Cutibacterium acnes recombinant phages, method of production and uses thereof1US 11,473,093 B2Eligo Bioscience · 2022